In duration-response analysis, 5 percent decrease seen in suicidal events per month of additional treatment
MONDAY, Oct. 3, 2022 (HealthDay News) — Folic acid seems to be beneficial for reducing the rate of suicide attempts, according to a study published online Sept. 28 in JAMA Psychiatry.
Robert D. Gibbons, Ph.D., from the University of Chicago, and colleagues used a within-person exposure-only cohort design to study the dynamic association of folic acid prescription fills with suicide attempts and intentional self-harm using data for patients with private health insurance. Data were included for 866,586 patients (81.30 percent female).
The researchers noted 261 suicidal events during the months covered by a folic acid prescription compared with 895 suicidal events during months without folic acid (rate, 4.73 versus 10.61 per 100,000 person-months). The hazard ratio for folic acid for suicide events was 0.56 when adjusting for age and sex, diagnoses related to suicidal behavior, diagnoses related to folic acid deficiency, folate-reducing medications, history of folate-reducing medications, and history of suicidal events; results were similar for the modal dosage of 1 mg per day and for women of childbearing age. A 5 percent decrease in suicidal events per month of additional treatment was seen in a duration-response analysis. No association was seen with suicide attempt in the same analysis with a control supplement.
“These results warrant the conduct of [a randomized clinical trial] with suicidal ideation and behavior as outcomes of interest,” the authors write. “If confirmed, folic acid may be a safe, inexpensive, and widely available treatment for suicidal ideation and behavior.”
Two authors disclosed financial ties to the pharmaceutical and other industries.
Abstract/Full Text (subscription or payment may be required)
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk
Children, Teens Have Higher Psychological Burden of Atopic Dermatitis
Proportion of ED Visits for Suspected Suicide Down From 2021 to 2025
Docosahexaenoic Acid Supplement Does Not Improve Cognitive Performance
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021
Exercise Link to Dementia Varies by Physical Activity Domain
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings